Salmon protein may ease menopause symptoms and help weight
NCT ID NCT07611305
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily supplement made from salmon protein (ProGo®) can help menopausal women manage their weight and improve quality of life. About 100 healthy, overweight women aged 40-65 will take either a low or high dose of ProGo® or a placebo for 18 weeks. Researchers will track changes in BMI and menopause-related symptoms like hot flashes, mood, and sleep.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Salmon protein hydrolysate (ProGo®)
What this could lead to
If it works, this could offer a natural supplement to help menopausal women manage weight and improve daily well-being.
What could go wrong
This is an early-stage trial with only 100 participants, so results may not apply to everyone. The supplement may not outperform placebo, and weight loss seen in prior studies was modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENOPAUSE RELATED CONDITIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alethios, Inc.
San Francisco, California, 94109, United States